Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(20)
Published: May 11, 2023
Abstract
Isocitrate
dehydrogenase
(IDH)
mutation,
a
known
pathologic
classifier,
initiates
metabolic
reprogramming
in
glioma
cells
and
has
been
linked
to
the
reaction
status
of
glioma‐associated
microglia/macrophages
(GAMs).
However,
it
remains
unclear
how
IDH
genotypes
contribute
GAM
phenotypes.
Here,
is
demonstrated
that
gliomas
expressing
mutant
determine
M1‐like
polarization
GAMs,
while
archetypal
induces
M2‐like
polarization.
Intriguingly,
IDH‐mutant
secrete
excess
cholesterol,
resulting
cholesterol‐rich,
pro‐inflammatory
GAMs
without
altering
their
cholesterol
biosynthesis,
simultaneously
exhibiting
low
levels
tumoral
due
expression
remodeling
transport
molecules,
particularly
upregulation
ABCA1
downregulation
LDLR.
Mechanistically,
miR‐19a/LDLR
axis‐mediated
novel
post‐transcriptional
regulation
uptake
identified,
modulated
by
influencing
tumor
cell
proliferation
invasion.
mutation‐induced
PERK
activation
enhances
export
from
via
axis
ABCA1/APOE
upregulation.
Further,
synthetic
activator,
CCT020312
introduced,
which
markedly
stimulates
efflux
wild‐type
cells,
consequently
suppresses
The
findings
reveal
an
essential
role
PERK/miR‐19a/LDLR
signaling
pathway
orchestrating
gliomal
subsequent
phenotypes
thereby
highlighting
potential
target
for
therapy.
Journal of Neurology Neurosurgery & Psychiatry,
Journal Year:
2025,
Volume and Issue:
unknown, P. jnnp - 334708
Published: April 1, 2025
Background
The
link
between
low-density
lipoprotein
cholesterol
(LDL-C)
levels
and
dementia
risk
is
poorly
understood,
with
conflicting
evidence
on
the
role
of
LDL-C
impact
statin
therapy
cognitive
outcomes.
Thus,
we
aimed
to
examine
association
assess
influence
therapy.
Methods
We
retrospectively
analysed
data
from
11
university
hospitals
participating
in
Observational
Medical
Outcomes
Partnership
(OMOP)
Common
Data
Model
(CDM).
Participants
a
prior
diagnosis
or
those
<180
days
observation
before
cohort
inclusion,
included
both
cohorts
were
excluded.
primary
outcome
was
all-cause
dementia,
secondary
being
Alzheimer’s
disease-related
(ADRD).
study
utilised
1:1
propensity
score
matching
compare
individuals
below
70
mg/dL
(1.8
mmol/L)
against
above
130
(3.4
mmol/L),
resulting
analysis
108
980
matched
patients.
Secondary
analyses
further
examined
thresholds
55
(1.4
use.
Results
associated
26%
reduction
28%
ADRD,
compared
mmol/L).
For
there
an
18%
for
Among
<70
(<1.8
use
13%
12%
decrease
ADRD
non-users.
Conclusion
Low
(<70
mmol/L))
are
significantly
reduced
including
providing
additional
protective
effects.
These
findings
support
necessity
targeted
lipid
management
as
preventive
strategy
indicating
importance
personalised
treatment
approaches.
Journal of Neuroinflammation,
Journal Year:
2022,
Volume and Issue:
19(1)
Published: July 11, 2022
The
complement
system
is
part
of
the
innate
immune
that
clears
pathogens
and
cellular
debris.
In
healthy
brain,
influences
neurodevelopment
neurogenesis,
synaptic
pruning,
clearance
neuronal
blebs,
recruitment
phagocytes,
protects
from
pathogens.
However,
excessive
downstream
activation
leads
to
generation
C5a,
C5a
engagement
with
its
receptor
C5aR1,
instigates
a
feed-forward
loop
inflammation,
injury,
death,
making
C5aR1
potential
therapeutic
target
for
neuroinflammatory
disorders.
ablation
in
Arctic
(Arc)
model
Alzheimer's
disease
against
cognitive
decline
injury
without
altering
amyloid
plaque
accumulation.
Acta Neuropathologica Communications,
Journal Year:
2022,
Volume and Issue:
10(1)
Published: March 16, 2022
Previous
studies
show
that
3β-hydroxysterol-Δ24
reductase
(DHCR24)
has
a
remarked
decline
in
the
brain
of
AD
patients.
In
cholesterol
synthetic
metabolism,
DHCR24
is
known
as
heavily
key
synthetase
synthesis.
Moreover,
mutations
gene
result
inhibition
enzymatic
activity
DHCR24,
causing
deficiency
and
desmosterol
accumulation.
Furthermore,
vitro
also
demonstrated
knockdown
lead
to
synthesis,
decrease
plasma
membrane
intracellular
level.
Obviously,
could
play
crucial
role
maintaining
homeostasis
via
control
Over
past
two
decades,
accumulating
data
suggests
downregulated
by
major
risk
factors
for
AD,
suggesting
potential
link
between
downregulation
pathogenesis.
Thus,
loss
seems
be
induced
possible
causative
AD.
According
previous
our
study,
we
further
found
reduced
level
compartments
obviously
was
involved
β-amyloid
generation,
tau
hyperphosphorylation,
apoptosis.
Importantly,
increasing
evidences
reveal
lipid
raft
disorganization
are
linked
neuropathological
impairments
which
associated
with
Therefore,
based
on
research
suppose
deficiency/loss
might
pathogenesis
Science Advances,
Journal Year:
2024,
Volume and Issue:
10(4)
Published: Jan. 24, 2024
The
brain-specific
enzyme
CYP46A1
controls
cholesterol
turnover
by
converting
into
24
S
-hydroxycholesterol
(24OH).
Dysregulation
of
brain
and
reduced
levels
are
observed
in
Alzheimer’s
disease
(AD).
In
this
study,
we
report
that
overexpression
aged
female
mice
leads
to
enhanced
estrogen
signaling
the
hippocampus
improved
cognitive
functions.
contrast,
age-matched
overexpressing
males
show
anxiety-like
behavior,
worsened
memory,
elevated
5α-dihydrotestosterone
hippocampus.
We
that,
neurons,
24OH
contributes
these
divergent
effects
activating
sex
hormone
signaling,
including
receptors.
protects
from
memory
impairments
induced
ovariectomy
while
having
no
gonadectomized
males.
Last,
measured
cerebrospinal
fluid
a
clinical
cohort
patients
with
AD
found
negatively
correlates
neurodegeneration
markers
only
women.
suggest
activation
is
valuable
pharmacological
target
for
enhancing
women
at
risk
developing
neurodegenerative
diseases.
BMC Geriatrics,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: May 30, 2024
Abstract
Background
Adverse
effects
of
rigorously
lowering
low-density
lipoprotein
cholesterol
on
cognition
have
been
reported;
therefore,
we
aimed
to
study
the
contribution
serum
in
cognitive
decline
older
people
with
or
without
dementia.
Methods
Cognitive
function
was
assessed
by
Abilities
Screening
Instrument
(CASI).
We
investigated
associations
between
using
multiple
regressions
controlling
for
demographics,
vascular
risk
factors,
and
treatments.
Results
Most
CASI
scores
could
be
explained
non-linear
inverted
U-shaped
relationships
(
R
2
=
0.003–0.006,
p
<
0.016,
Šidákcorrection).
The
were
most
evident
changes
at
preclinical
prodromal
stages
dementia
(R
0.02–0.064,
values
0.016).
There
no
differences
level
individuals
1st
decile
10th
groups
0.266–0.972).
However,
triglyceride
stable
normal
functions
showed
significant
improvement
compared
those
t
(202)
2.275,
0.05).
Conclusion
These
findings
implicate
that
may
not
suitable
prevention
among
people,
especially
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(11), P. 1362 - 1362
Published: Oct. 26, 2024
Aging
induces
complex
changes
in
the
lipid
profiles
across
different
areas
of
brain.
These
can
affect
function
brain
cells
and
may
contribute
to
neurodegenerative
diseases
such
as
Alzheimer's
disease.
Research
shows
that
while
overall
profile
human
remains
quite
steady
throughout
adulthood,
specific
occur
with
age,
especially
after
age
50.
include
a
slow
decline
total
content
shifts
composition
fatty
acids,
particularly
glycerophospholipids
cholesterol
levels,
which
vary
depending
on
region.
Lipid
rafts
play
crucial
role
maintaining
membrane
integrity
facilitating
cellular
signaling.
In
context
disease,
have
been
associated
development
For
example,
alterations
raft
lead
increased
accumulation
amyloid
β
(Aβ)
peptides,
contributing
neurotoxic
effects.
droplets
store
neutral
lipids
are
key
for
energy
metabolism.
As
organisms
dynamics
change,
evidence
suggesting
metabolic
activity
over
time.
This
reduced
an
imbalance
synthesis
mobilization,
processes.
model
like
Drosophila,
studies
shown
metabolism
be
influenced
by
diet
insulin
signaling
pathways,
balance.
The
interplay
between
metabolism,
oxidative
stress,
inflammation
is
critical
aging
peroxidation,
consequence
formation
reactive
aldehydes
further
damage
neurons.
Inflammatory
processes
also
disrupt
pathology
AD.
Consequently,
oxidized
integrity,
influencing
pathways
involved
neuronal
survival
function.
Frontiers in Neuroscience,
Journal Year:
2022,
Volume and Issue:
15
Published: Jan. 12, 2022
Alzheimer’s
disease
(AD)
is
characterised
by
synaptic
dysfunction
accompanied
the
microscopically
visible
accumulation
of
pathological
protein
deposits
and
cellular
dystrophy
involving
both
neurons
glia.
Late-stage
AD
shows
pronounced
loss
synapses
across
several
differentially
affected
brain
regions.
Recent
studies
advanced
using
post-mortem
samples
have
demonstrated
direct
involvement
microglia
in
changes.
Variants
Apolipoprotein
E
Triggering
Receptors
Expressed
on
Myeloid
Cells
gene
represent
important
determinants
microglial
activity
but
also
lipid
metabolism
cells
central
nervous
system.
Here
we
review
evidence
that
may
help
to
explain
how
abnormal
metabolism,
activation,
pathophysiology
are
inter-related
AD.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(3), P. 2876 - 2876
Published: Feb. 2, 2023
Precision
neurology
combines
high-throughput
technologies
and
statistical
modeling
to
identify
novel
disease
pathways
predictive
biomarkers
in
Alzheimer's
(AD).
Brain
cytochrome
P450
(CYP)
genes
are
major
regulators
of
cholesterol,
sex
hormone,
xenobiotic
metabolism,
they
could
play
important
roles
neurodegenerative
disorders.
Increasing
evidence
suggests
that
epigenetic
factors
contribute
AD
development.
We
evaluated
cytosine
('CpG')-based
DNA
methylation
changes
using
circulating
cell-free
(cfDNA),
which
neuronal
cells
known
contribute.
investigated
CYP-based
mechanisms
for
pathogenesis
detection.
performed
a
case-control
study
25
patients
with
23
cognitively
healthy
controls
the
cfDNA
CYP
genes.
logistic
regression
analysis
MetaboAnalyst
software
computer
program
molecular
pathway
based
on
epigenetically
altered
Cytoscape
program.
identified
130
significantly
(false
discovery
rate
correction
q-value
<
0.05)
differentially
methylated
CpG
sites
within
The
top
two
were
CYP51A1
CYP2S1.
significant
perturbed
(i)
androgen
estrogen
biosynthesis
(ii)
C21
steroid
hormone
(iii)
arachidonic
acid
metabolism.
Existing
potential
role
each
these
biochemical
pathogenesis.
Next,
we
randomly
divided
group
into
validation
sub-sets,
consisting
control
patients.
Regression
models
prediction
markers
developed
or
training
tested
independent
group.
achieved
high
accuracy.
After
10-fold
cross-validation,
combination
cg17852385/cg23101118
+
cg14355428/cg22536554
an
AUC
(95%
CI)
0.928
(0.787~1.00),
100%
sensitivity
92.3%
specificity
detection
performance
remained
test
group,
achieving
0.942
(0.905~0.979)
90%
specificity.
Our
findings
suggest
modification
may
have
accurately
non-invasively
detect
AD.
Frontiers in Aging Neuroscience,
Journal Year:
2023,
Volume and Issue:
15
Published: Feb. 10, 2023
We
postulate
that
myelin
injury
contributes
to
cholesterol
release
from
and
dysmetabolism
which
Abeta
dysmetabolism,
combined
with
genetic
AD
risk
factors,
leads
increased
amyloid
plaques.
Increased
damages
form
a
vicious
cycle.
Thus,
white
matter
injury,
interact
produce
or
worsen
neuropathology.
The
cascade
is
the
leading
hypothesis
for
cause
of
Alzheimer’s
disease
(AD).
failure
clinical
trials
based
on
this
has
raised
other
possibilities.
Even
possible
new
success
(Lecanemab),
it
not
clear
whether
result
disease.
With
discovery
in
1993
apolipoprotein
E
type
4
allele
(APOE4)
was
major
factor
sporadic,
late-onset
(LOAD),
there
been
increasing
interest
since
APOE
transporter.
Recent
studies
show
metabolism
intricately
involved
(Aβ)/amyloid
transport
metabolism,
down-regulating
Aβ
LRP1
transporter
upregulating
RAGE
receptor,
both
would
increase
brain
Aβ.
Moreover,
manipulating
rodent
models
can
ameliorate
pathology
cognitive
deficits,
them
depending
upon
manipulation.
Though
(WM)
noted
initial
observations,
recent
have
shown
abnormal
every
brain.
age-related
WM
normal
individuals
occurs
earlier
worse
APOE4
genotype.
precedes
formation
plaques
tangles
human
Familial
(FAD)
plaque
models.
Restoring
improves
cognition
without
affecting
pathology.
we
cascade,
and/or
further
primary
initiating
event
could
be
related
any
three,
age
diet
genes
FAD
dysmetabolism.